Overall, knowledge on Ago2 protein, which potentially guides the siRNA for endonuclease activity, would provide a baseline understanding at the atomic level in regard to the RNAi mechanism for treating ALS disorder. This evidence concerns the gene AGO2 and amyotrophic lateral sclerosis.